Philip P. Breitfeld - Oct 12, 2022 Form 4 Insider Report for CHAMPIONS ONCOLOGY, INC. (CSBR)

Role
Director
Signature
/s/ Philip P. Breitfeld
Stock symbol
CSBR
Transactions as of
Oct 12, 2022
Transactions value $
-$2
Form type
4
Date filed
10/14/2022, 02:25 PM
Previous filing
Nov 9, 2021
Next filing
Aug 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSBR Common Stock Options Exercise $26.7K +8.33K +84.45% $3.21 18.2K Oct 12, 2022 Direct
transaction CSBR Common Stock Tax liability -$26.8K -3.56K -19.57% $7.51 14.6K Oct 12, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CSBR Option to purchase Common Stock Options Exercise $0 -8.33K -100% $0.00* 0 Oct 12, 2022 Common Stock 8.33K $3.21 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a "net exercise" of outstanding stock opitons. These shares were witheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, common stock on October 12, 2022.
F2 The options vest and are exercisable over a twelve month period, with vesting to occur on November 8, 2017, February 8, 2018, May 8, 2018 and August 8, 2018